Have you ever run it solo? I***8217;m very keen to hear of anyone who hasn***8217;t run it in a cycle, if there***8217;s anyone in that boat.
I***8217;m meeting with the endo in a week and he is happy to run me on a course and monitor all my bloods for 3 months. It seems that there is no one off pill for lowering SHBG out there and because all my other levels are ok he thinks in this case he***8217;s happy to write the script.
I***8217;m just concerned about any negative effects on supressing my natural T it***8217;s going to have.
Yes, I have run it as a Bridge between Cycles.
Proviron isn't Suppressive to Low or Normal LH and FSH, at Doses of 100 to 150 Mg a Day for 12 Months.
There's a Clinical Study that was done.
In another Clinical Study, Proviron was shown to be Suppressive @ doses of 300 to 450 Mg a Day.
This was done to study it's effects on Depressed Patients.
I can't even Imagine doing that much.
I'd have a Priapism............................................. JP
P.S.
Here's a couple Paragraphs from the Clinical Studies.
Two hundred fifty subfertile men with idiopathic oligospermia (count less than 20 million/ml) were treated with mesterolone (100-150 mg/day) for 12 months. Seminal analysis were assayed 3 times and serum follicle stimulating hormone (FSH) luteinizing hormone (LH) and plasma testosterone were assayed once before treatment and repeated at 3, 6, 9 and 12 months after the initiation of treatment. One hundred ten patients (44%) had normal serum FSH, LH and plasma testosterone, 85 patients (34%) had low serum FSH, LH and low plasma testosterone. One hundred seventy-five patients (70%) had moderate oligospermia (count 5 to less than 20 million/ml) and 75 patients (30%) had severe oligospermia (count less than 5 million/ml). Seventy-five moderately oligospermic patients showed significant improvement in the sperm density, total sperm count and motility following mesterolone therapy whereas only 12% showed improvement in the severe oligospermic group. [B
]Mesterolone had no depressing effect on low or normal serum FSH and LH levels but had depressing effect on 25% if the levels were [/B]elevated. There was no significant adverse effect on testosterone levels or on liver function. One hundred fifteen (46%) pregnancies resulted following the treatment, 9 of 115 (7.8%) aborted and 2 (1.7%) had ectopic pregnancy. Mesterolone was found to be more useful in patients with a sperm count ranging between 5 and 20 million/ml. Those with severe oligospermia (count less than 5 million) do not seem to benefit from this therapy.
Based on computer EEG (CEEG) profiles, in high doses, antidepressant properties of mesterolone, a synthetic androgen, were predicted. In a double-blind placebo controlled study,
the clinical effects of 300-450 mg daily mesterolone were investigated in 52 relatively young (age range 26-53 years, mean 42.7 years) male depressed outpatients. During 6 weeks of mesterolone treatment, there was a significant improvement of depressive symptomatology. However, since an improvement was also established during the placebo treatment, no statistically appreciable difference in the therapeutic effects of mesterolone was established compared to placebo.
Mesterolone treatment significantly decreased both plasma testosterone and protein bound testosterone levels. Patients with high testosterone levels prior to treatment seem to have had more benefit from mesterolone treatment than patients with low testosterone levels. The degree of improvement weakly correlated to the decrease of testosterone levels during mesterolone treatment.